2016-2020 Opportunities in the World Cancer Diagnostics Market: Emerging Tests, Innovative Technologies, Instrumentation Review, Sales Forecasts by Country, Strategic Profiles of Leading Suppliers

March 2016 | 510 pages | ID: 283290780C2EN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch.com provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents:

• Estimated numbers of cancer testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U. K. and U. S.

• Marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

• Overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new technologies, products, and applications.

• Review of current instrumentation used for cancer diagnostic testing.

• Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing.

• Competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

• Profiles of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 510 pages and 31 tables

Contents

I. Worldwide Business Environment
II. Worldwide Market Structure
III. Major Current And Emerging Cancer Diagnostic Tests
  1. INTRODUCTION
  2. Tumor Marker Classification
  3. ACTH
  4. Alpha  Fetoprotein (AFP)
  5. Beta  2 Microglobulin
  6. CA  15  3/27.29
  7. CA  19  9
  8. CA  125
  9. Calcitonin
  10. Carcinoembrionic Antigen (CEA)
  11. Estrogen and Progesterone Receptors
  12. Ferritin
  13. Gastrin
  14. Human Chorionic Gonadotropin (HCG)
  15. Insulin
  16. NSE
  17. OCCULT BLOOD
  18. PAP Smear/HPV
  19. Prostatic Acid Phosphatase (PAP)
  20. Prostate  Specific Antigen (PSA)
  21. Squamous Cell Carcinoma Antigen (SCC)
  2. T AND B LYMPHOCYTES
  3. TDT
  24. Thyroglobulin
  25. Tissue Polypeptide Antigen (TPA)
  26. Biochemical Tumor Markers
ADA
B Protein
PNP
    5'  Nucleotidase
  7. ONCOGENES
Abl/abl  bcr
AIB1
BCL  2
BRCA1
CD44
C  fos
C  myb
C  myc
CYP  17
Erb  B
HPC1
N  myc
P40P51P53
PIK3CAPTI  1
Ras
Reg
Sis
Src
  28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
Beta  TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor  Alpha
  29. Ectopic Hormones
  30. Colony Stimulating Factors
  31. Lymphokines
Alpha  Interferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma  Interferon
Interleukin  1 (IL  1)
Macrophage Activating Factor
  32. Immunohistochemical Stains
  33. Emerging Tumor Markers
N  Acetylglucosamine
Actin
Alpha  Actin
Antineuronal Antibodies
    7B2
B72.3
Bax
BCD  F9BLCA  4
Blood Group Antigens A,B,H
CA
CA  72  4/TAG  72
CA
CA  242
CA  549
CAM
CAR  3
Cathepsin  D
Chromogranin A and B
Cluster  1 Antigen
Cluster  5/5A Antigen
CTACU18 DR  70 DU  PAN  2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1  >3)  L  fucosyltransferase
Gastrin  Releasing Peptide (GRP)
GDCFP  15
Glucagon
Glycoamines
H23
Her  2
Human Carcinoma Antigen
HPA HSP27
Intermediate Filaments
Cytokeratins/CK18/Cyfra  21  1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma  695/Ma
MABDF3
MAG ME1
Minactivin
MN/CA9 MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA  130 NMP22
OA  519
Opiod Peptides
P  glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative Index, Ki  67
Px
RB Inactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA  1/SLX
SN10
Somatostatin
TA  90 TABA
Tachykinin
TAG
TPS
Troponin
Tubulin
VCAM VEGF
Villen

IV. INSTRUMENTATION REVIEW: LEADING ANALYZERS MARKETED BY ABBOTT, BECKMAN COULTER/DANAHER, BINDING SITE, BIOMERIEUX, CAROLINA CHEMISTRIES, DIASORIN, HORIBA, INVERNESS/ALERE, J&J, OLYMPUS, ROCHE, SIEMENS, TOSOH, VITAL DIAGNOSTICS AND OTHER SUPPLIERS

V. Current and Emerging Technologies
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    b. Radioimmunoassay (RIA)
    c. Enzyme Immunoassays (EIA)
Overview

ELISA

Immunofiltration
Particle  Membrane Capture Immunoassay
Enzyme Amplification
    d. Fluorescent Immunoassays
    e. Luminescence
Chemiluminescence
Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
    e. Liposome Flow  Injection Immunoassay

3. MOLECULAR DIAGNOSTICS

    a. Technology Overview
    b. Amplification Methods

4. CHROMOSOME ANALYSIS

    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes

5. ARTIFICIAL INTELLIGENCE

6. FLOW CYTOMETRY

7. TW      DIMENSIONAL GEL ELECTROPHORESIS (2  DGE)

8. BIOSENSORS

  9. Competing/Complementing Technologies
    a. CT
    b. MRI
    c. NMR
    d. PET
    e. Photonics Spectroscopy

VI. COMPETITIVE PROFILES

Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio  Rad
CellSearch
Cepheid
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Hologic/Gen  Probe
Guided Therapeutics
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho  Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo Fisher
Vermillion/Correlogic Systems
Wako Pure Chemicals
Wallac/PE
Zila
Appendixes: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

List Of Tables

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta  2 Microglobulin Tests
Major Companies Developing or Marketing CA  15  3/27.29 Tests
Major Companies Developing or Marketing CA  19  9 Tests
Major Companies Developing or Marketing CA  125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic Testing By Country
Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By Country
Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By Country